knowledge -WSS

knowledge

author：leisure time 2025-09-03 09:25:14 - browse：2372

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： States should stop sabotaging methadone treatment reform

leisure time

WSS

Neutralizing antibodies against HIV shows promise in children

Steward Health Care has deal to sell doctor network to UnitedHealth

UPS workers' union leader explains what's at stake as strike edges closer

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Oprah kicked off a national conversation on obesity. Let's have it

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

focus

knowledge

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Neutralizing antibodies against HIV shows promise in children

Alkermes shareholders re

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Activists slam private health insurers over coverage restrictions

Sen. Bill Cassidy on how to lower drug prices

What does generative AI mean for health care? We asked experts

US intelligence assessment says Iran not currently developing nuclear weapons

Drug repurposing or repositioning? The language matters

Why Titanic fascinates society, still drawing tours to the wreckage

focus

Scientists boost immune system in aging mice by making it youthful

Washington mulls new rules to avert another Change Healthcare

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

UPS workers' union leader explains what's at stake as strike edges closer

Patient advocates debate FDA's accelerated approval process

knowledge

explore

leisure time

hotspot